{"DataElement":{"publicId":"3860671","version":"2","preferredName":"Baseline Neoplasm Non-Measurable RECIST Type","preferredDefinition":"The type of lesion or lymph node identified at baseline not meeting minimum size requirements as defined in the RECISTv1.1 guideline.","longName":"BSL_NMSR_LES_TP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3853566","version":"2","preferredName":"Baseline Neoplasm Non-Measurable","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A starting point to which things may be compared._Not possible to be measured.","longName":"5946392v1.0:5946418v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"5946392","version":"1","preferredName":"Baseline Neoplasm","preferredDefinition":"A starting point to which things may be compared.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25213:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"580DC567-72BD-688B-E053-F662850AD4CF","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5946418","version":"1","preferredName":"Non-Measurable","preferredDefinition":"Not possible to be measured.","longName":"C25589","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Measurable","conceptCode":"C25589","definition":"Not possible to be measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"580EB693-A984-70F2-E053-F662850AD6A6","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"580EB693-A963-70F2-E053-F662850AD6A6","latestVersionIndicator":"Yes","beginDate":"2013-08-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"TAYLORT","dateModified":"2017-08-31","changeDescription":"8/31/17 tt DEC versioned for change to concepts, long name; transferred Context, added CSI and reg status per Round 5 finalization task.   6/29/16 released. jk 8/12/13 created for RECISTv1.1 CRF module. Jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3860648","version":"2","preferredName":"RECIST Non-Measurable Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)._Something distinguishable as an identifiable class based on common qualities.","longName":"3860648v2.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"7","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Lymphangitic involvement of skin or lung","valueDescription":"Involvement Skin Lung Lymphatic System","ValueMeaning":{"publicId":"3909894","version":"1","preferredName":"Involvement Skin Lung Lymphatic System","longName":"3909894","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.: An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.: One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: (lim-FAT-ik SIS-tem) The tissues and organs that produce, store, and carry white blood cells that fight infections and other diseases. This system includes the bone marrow, spleen, thymus, lymph nodes, and lymphatic vessels (a network of thin tubes that carry lymph and white blood cells).  Lymphatic vessels branch, like blood vessels, into all the tissues of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphatic System","conceptCode":"C12746","definition":"The anatomic system that includes the lymph nodes, lymphoid tissues in various organs (spleen, thymus, tonsils, gastrointestinal tract), and lymphatic vessels.  It is part of the immune system that offers protection against infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7635FB4-FF93-BDA0-E040-BB89AD437F9E","latestVersionIndicator":"Yes","beginDate":"2013-09-27","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-4937-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Abdominal masses","valueDescription":"Abdominal Mass","ValueMeaning":{"publicId":"3860650","version":"1","preferredName":"Abdominal Mass","longName":"3860650","preferredDefinition":"Of, or related to, the abdomen.: A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells, inflammatory cells, or cystic changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdominal","conceptCode":"C25342","definition":"Of, or related to, the abdomen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mass","conceptCode":"C34808","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells, inflammatory cells, or cystic changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4697DB6-3F2E-DAA4-E040-BB89AD434B4A","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-494B-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Inflammatory breast disease","valueDescription":"Inflammatory Breast Disease or Disorder","ValueMeaning":{"publicId":"3860652","version":"1","preferredName":"Inflammatory Breast Disease or Disorder","longName":"3860652","preferredDefinition":"Inflammatory; relating to inflammation.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory","conceptCode":"C25535","definition":"Relating to inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4697DB6-3F78-DAA4-E040-BB89AD434B4A","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-4955-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Ascites","valueDescription":"Ascites","ValueMeaning":{"publicId":"3123209","version":"1","preferredName":"Ascites","longName":"3123209v1.00","preferredDefinition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal Effusion","conceptCode":"C2885","definition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBD6A24-E461-9B0C-E040-BB89AD430E98","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-07-19","modifiedBy":"KUMMEROA","dateModified":"2023-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-4969-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Leptomeningeal disease","valueDescription":"Leptomeninges Disease or Disorder","ValueMeaning":{"publicId":"3860654","version":"1","preferredName":"Leptomeninges Disease or Disorder","longName":"3860654","preferredDefinition":"The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leptomeninges","conceptCode":"C32979","definition":"The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4697DB6-3FD0-DAA4-E040-BB89AD434B4A","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-4973-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Bone lesions","valueDescription":"Bone Lesion","ValueMeaning":{"publicId":"3860638","version":"1","preferredName":"Bone Lesion","longName":"3860638","preferredDefinition":"Connective tissue that forms the skeletal components of the body.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone","conceptCode":"C12366","definition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E469528A-7C37-269F-E040-BB89AD435850","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"ONEDATA","dateModified":"2013-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-497D-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Cystic lesions","valueDescription":"Cyst Lesion","ValueMeaning":{"publicId":"3860637","version":"1","preferredName":"Cyst Lesion","longName":"3860637","preferredDefinition":"A sac-like closed membranous structure that may be empty or contain fluid or amorphous material.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cyst","conceptCode":"C2978","definition":"A sac-like closed membranous structure that may be empty or contain fluid or amorphous material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E469528A-7C14-269F-E040-BB89AD435850","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"TAYLORT","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-4987-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Abdominal organomegaly","valueDescription":"Abdominal Organomegaly","ValueMeaning":{"publicId":"4821411","version":"1","preferredName":"Abdominal Organomegaly","longName":"4821411","preferredDefinition":"Of, or related to, the abdomen.: An abnormal enlargement of an organ, particularly an organ of the abdominal cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdominal","conceptCode":"C25342","definition":"Of, or related to, the abdomen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Organomegaly","conceptCode":"C121827","definition":"An abnormal enlargement of an organ, particularly an organ of the abdominal cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"158504CD-36BC-791F-E050-BB89AD431C92","latestVersionIndicator":"Yes","beginDate":"2015-05-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580ED5B7-49AF-062C-E053-F662850A38C3","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Tumor lesions","valueDescription":"Neoplasm Lesion","ValueMeaning":{"publicId":"5946398","version":"1","preferredName":"Neoplasm Lesion","longName":"5946398","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"580E6344-CB92-08D5-E053-F662850AA0AA","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580F01F8-86A2-0F6E-E053-F662850A2F16","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Lesions with prior local treatment","valueDescription":"Lesion With Prior Local Therapy","ValueMeaning":{"publicId":"5946399","version":"1","preferredName":"Lesion With Prior Local Therapy","longName":"5946399","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.: Used to indicate the presence of something or someone.: Earlier in time or order.: Any therapeutic procedure that targets, or is restricted to, a specific anatomical location.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Local Therapy","conceptCode":"C15687","definition":"Any therapeutic procedure that targets, or is restricted to, a specific anatomical location.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"580E6344-CBBA-08D5-E053-F662850AA0AA","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"TAYLORT","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580F01F8-86AC-0F6E-E053-F662850A2F16","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Malignant lymph node","valueDescription":"Malignant Lymph Node","ValueMeaning":{"publicId":"3860655","version":"1","preferredName":"Malignant Lymph Node","longName":"3860655","preferredDefinition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4697DB6-404C-DAA4-E040-BB89AD434B4A","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580F01F8-86B6-0F6E-E053-F662850A2F16","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"},{"value":"Pleural or pericardial effusion","valueDescription":"Pericardial or pleural effusions","ValueMeaning":{"publicId":"3860653","version":"1","preferredName":"Pericardial or pleural effusions","longName":"3860653","preferredDefinition":"Of or pertaining to the pleura.: Located around the heart or relating to or affecting the pericardium.: A collection of fluid in a body cavity, which may be the result of a non-neoplastic disorder (e.g. heart failure) or a tumor (e.g. carcinoma of the lung).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleural","conceptCode":"C25223","definition":"Of or pertaining to the pleura.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pericardial","conceptCode":"C38001","definition":"Located around the heart or relating to or affecting the pericardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Effusion","conceptCode":"C3003","definition":"A collection of fluid in a body cavity, which may be the result of a non-neoplastic disorder (e.g. heart failure) or a tumor (e.g. carcinoma of the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4697DB6-3F9F-DAA4-E040-BB89AD434B4A","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"580F01F8-86CA-0F6E-E053-F662850A2F16","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3272579","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com):Type; a subdivision of a particular kind of thing.","longName":"C49164:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACEA336D-9BE1-9D02-E040-BB89AD43428D","latestVersionIndicator":"Yes","beginDate":"2011-09-14","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-09-14","modifiedBy":"ONEDATA","dateModified":"2011-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"580ED5B7-491F-062C-E053-F662850A38C3","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard for RECIST defined PV list; do not add PVs without checking latest version of guideline.  8/31/17 tt VD versioned for changes to concepts, LN, max length and PVs; transferred Context, added CSI and reg status per Round 5 finalization task.  6/19/16 removed qualifier concepts per current BP; released. jk 5/7/15 removed dup PV that did not have CUIs; added CUIs for abdominal organomegaly. jc 9/27/13 added concept codes for lymphatic system value. jc 8/20/13 created for RECIST CRF module; values based on definitions in RECISTv1.1 guideline, section 3.1.2 and 3.1.3. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3794651","version":"1","longName":"RECIST CRF","context":"NCIP"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006643","version":"1","longName":"RECISTv1.1","context":"NCI Standards"},{"publicId":"6006642","version":"1","longName":"irRECIST","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Baseline non-measurable lesion","type":"Preferred Question Text","description":"Baseline non-measurable lesion","url":null,"context":"NCI Standards"},{"name":"irRECIST","type":"COMMENT","description":"Non-target lesions will include: Measurable lesions not selected as target lesions OR All sites of non-measurable disease,such as neoplastic masses that are too small to measure because their longest uninterrupted diameter is < 10 mm (or < two times the axial slice thickness), ie. the longest per-pendicular diameter is ≥10 and < 15 mm OR Other types of lesions that are confidently felt to represent neoplastic tissue, but are difficult to measure in a reproducible manner. These include bone metastases, leptomeningeal metastases, malignant ascites, pleural or pericardial effusions, ascites, inflammatory breast disease, lymphangitis cutis/pulmonis, cystic lesions, ill-defined abdominal masses, skin lesions, etc.","url":"https://www.parexel.com/files/7914/2186/7838/irrecist-path-PDF.pdf","context":"NCI Standards"},{"name":"CRF Text","type":"Alternate Question Text","description":"Non-measurable lesion type","url":null,"context":"NCI Standards"},{"name":"RECIST","type":"Alternate Question Text","description":"Baseline non-measurable lesion","url":null,"context":"NCI Standards"},{"name":"irRECIST","type":"Alternate Question Text","description":"Baseline non-measurable lesion type","url":null,"context":"NCI Standards"}],"origin":"RECISTv1.1:Response Evaluation Criteria in Solid Tumors v1.1","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"580F2956-4D3A-1017-E053-F662850A356F","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeDescription":"10/9/18 tt change to upper case \"Non\" in question text.  10/7/18 jk Added baseline to PQT per RECIST FG recommendation. 8/31/17 tt CDE versioned for changes to short name, long name, DEC and VD; transferred Context, changed quest, reg status per Round 5 finalization task.  6/19/16 released. jk 11/20/13 changed origin to RECISTv1.1. jc  8/20/13 created for RECIST CRF module; values based on definitions in RECISTv1.1 guideline, sections 3.1.2 and 3.1.3. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}